On this episode of Managed Care Cast, we discuss senior health needs amid the pandemic and how Centerwell Senior Primary Care's holistic, team-based approach and value-based care delivery contributed to upticks in senior patient visits despite fears of COVID-19.
As COVID-19 poses significant health risks for vulnerable populations nationwide, increased preventive considerations are warranted to manage concerns from patients and ensure that delivery of health care is maintained. Specific to senior populations, efforts to curb fears of COVID-19 through telehealth may also pose significant barriers to care.
On this episode of Managed Care Cast, we speak with Reneé Buckingham, segment president of Humana’s Care Delivery Organization, including CenterWell Senior Primary Care and Conviva Care Solutions, on how Centerwell not only maintained care utilization during the pandemic, but experienced upticks in senior patient visits.
Buckingham further discussed the implications of adopting a holistic, team-based approach for seniors and the benefits of value-based care delivery.
Listen above or through one of these podcast services:
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More